• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精性肝病中的肠道微生物群:致病作用及治疗前景

Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives.

作者信息

Malaguarnera Giulia, Giordano Maria, Nunnari Giuseppe, Bertino Gaetano, Malaguarnera Michele

机构信息

Giulia Malaguarnera, Michele Malaguarnera, Department of Clinical and Molecular Biomedicine, Section of Pharmacology and Biochemistry, 95100 Catania, Italy.

出版信息

World J Gastroenterol. 2014 Nov 28;20(44):16639-48. doi: 10.3748/wjg.v20.i44.16639.

DOI:10.3748/wjg.v20.i44.16639
PMID:25469033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4248208/
Abstract

Alcoholic liver disease (ALD) is the commonest cause of cirrhosis in many Western countries and it has a high rate of morbidity and mortality. The pathogenesis is characterized by complex interactions between metabolic intermediates of alcohol. Bacterial intestinal flora is itself responsible for production of endogenous ethanol through the fermentation of carbohydrates. The intestinal metabolism of alcohol produces a high concentration of toxic acetaldehyde that modifies gut permeability and microbiota equilibrium. Furthermore it causes direct hepatocyte damage. In patients who consume alcohol over a long period, there is a modification of gut microbiota and, in particular, an increment of Gram negative bacteria. This causes endotoxemia and hyperactivation of the immune system. Endotoxin is a constituent of Gram negative bacteria cell walls. Two types of receptors, cluster of differentiation 14 and Toll-like receptors-4, present on Kupffer cells, recognize endotoxins. Several studies have demonstrated the importance of gut-liver axis and new treatments have been studied in recent years to reduce progression of ALD modifying gut microbiota. It has focused attention on antibiotics, prebiotics, probiotics and synbiotics.

摘要

酒精性肝病(ALD)是许多西方国家肝硬化最常见的病因,其发病率和死亡率都很高。发病机制的特点是酒精代谢中间产物之间存在复杂的相互作用。肠道细菌菌群自身可通过碳水化合物发酵产生内源性乙醇。酒精的肠道代谢会产生高浓度的有毒乙醛,这会改变肠道通透性和微生物群平衡。此外,它还会导致肝细胞直接损伤。长期饮酒的患者肠道微生物群会发生改变,尤其是革兰氏阴性菌数量增加。这会导致内毒素血症和免疫系统过度激活。内毒素是革兰氏阴性菌细胞壁的组成成分。库普弗细胞上存在的两种受体,即分化抗原簇14和Toll样受体4,可识别内毒素。多项研究已证明肠-肝轴的重要性,近年来人们研究了新的治疗方法,以通过改变肠道微生物群来减缓ALD的进展。这已将注意力集中在抗生素、益生元、益生菌和合生元上。

相似文献

1
Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives.酒精性肝病中的肠道微生物群:致病作用及治疗前景
World J Gastroenterol. 2014 Nov 28;20(44):16639-48. doi: 10.3748/wjg.v20.i44.16639.
2
Microbiota-based treatments in alcoholic liver disease.基于微生物群的酒精性肝病治疗方法。
World J Gastroenterol. 2016 Aug 7;22(29):6673-82. doi: 10.3748/wjg.v22.i29.6673.
3
Gut microbiota and host metabolism in liver cirrhosis.肝硬化中的肠道微生物群与宿主代谢
World J Gastroenterol. 2015 Nov 7;21(41):11597-608. doi: 10.3748/wjg.v21.i41.11597.
4
Gut-liver axis in alcoholic liver disease.酒精性肝病中的肠-肝轴
Gastroenterology. 2015 Jan;148(1):30-6. doi: 10.1053/j.gastro.2014.10.042. Epub 2014 Nov 11.
5
Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.肠道微生物群:非酒精性脂肪性肝病的新治疗靶点。
Expert Rev Gastroenterol Hepatol. 2019 Mar;13(3):193-204. doi: 10.1080/17474124.2019.1569513. Epub 2019 Jan 25.
6
Alcoholic liver disease: the gut microbiome and liver cross talk.酒精性肝病:肠道微生物群与肝脏的相互作用
Alcohol Clin Exp Res. 2015 May;39(5):763-75. doi: 10.1111/acer.12704.
7
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.肠道微生物群和Toll样受体在非酒精性脂肪性肝病中的作用。
World J Gastroenterol. 2014 Jun 21;20(23):7381-91. doi: 10.3748/wjg.v20.i23.7381.
8
Synbiotics reduce ethanol-induced hepatic steatosis and inflammation by improving intestinal permeability and microbiota in rats.合生素通过改善大鼠肠道通透性和微生物群来减少乙醇诱导的肝脂肪变性和炎症。
Food Funct. 2015 May;6(5):1692-700. doi: 10.1039/c5fo00104h.
9
Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.肠-肝轴与益生菌:它们在非酒精性脂肪性肝病中的作用
World J Gastroenterol. 2014 Nov 14;20(42):15518-31. doi: 10.3748/wjg.v20.i42.15518.
10
The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD.肠道微生物群作为治疗非酒精性脂肪性肝病和酒精性肝病的治疗靶点。
Biomed Pharmacother. 2021 Mar;135:111235. doi: 10.1016/j.biopha.2021.111235. Epub 2021 Feb 6.

引用本文的文献

1
Autobrewery Syndrome and Endogenous Ethanol Production in Patients with MASLD: A Perspective from Chronic Liver Disease.非酒精性脂肪性肝炎患者的自动酿酒综合征和内源性乙醇生成:来自慢性肝病的视角
Int J Mol Sci. 2025 Jul 30;26(15):7345. doi: 10.3390/ijms26157345.
2
Exploring the Gut and Oral Microbiomes in Psychoactive Substance Use: A Scoping Review of Clinical Studies.探索精神活性物质使用中的肠道和口腔微生物群:临床研究的范围综述
J Neurochem. 2025 Jul;169(7):e70165. doi: 10.1111/jnc.70165.
3
A two-hit model in biliary atresia: cooperative viral-bacterial activation of MMP7 via TLR4/NF-κB signaling.胆管闭锁的双打击模型:通过TLR4/NF-κB信号通路实现病毒-细菌对MMP7的协同激活
Pediatr Res. 2025 Jun 18. doi: 10.1038/s41390-025-04242-3.
4
Biliary atresia: Rotavirus amplification of lipopolysaccharide/toll-like receptor 4 by mediating MMP7 upregulation through NF-κB.胆道闭锁:轮状病毒通过核因子κB介导基质金属蛋白酶7上调来增强脂多糖/ Toll样受体4的作用
Pediatr Res. 2025 May 25. doi: 10.1038/s41390-025-04128-4.
5
Diet, gut microbiota, and health: a review.饮食、肠道微生物群与健康:综述
Food Sci Biotechnol. 2024 Nov 25;34(10):2087-2099. doi: 10.1007/s10068-024-01759-x. eCollection 2025 Jun.
6
A biomarker framework for liver aging: the Aging Biomarker Consortium consensus statement.肝脏衰老的生物标志物框架:衰老生物标志物联盟共识声明。
Life Med. 2024 Jan 30;3(1):lnae004. doi: 10.1093/lifemedi/lnae004. eCollection 2024 Feb.
7
Metagenomics Reveals Sex-Based Differences in Murine Fecal Microbiota Profiles Induced by Chronic Alcohol Consumption.宏基因组学揭示长期饮酒诱导的小鼠粪便微生物群特征的性别差异。
Int J Mol Sci. 2024 Nov 22;25(23):12534. doi: 10.3390/ijms252312534.
8
Green Radish Polysaccharide Prevents Alcoholic Liver Injury by Interfering with Intestinal Bacteria and Short-Chain Fatty Acids in Mice.绿萝多糖通过干预小鼠肠道细菌和短链脂肪酸预防酒精性肝损伤。
Foods. 2024 Nov 22;13(23):3733. doi: 10.3390/foods13233733.
9
From Cirrhosis to the Dysbiosis (A Loop of Cure or Complications?).从肝硬化到菌群失调(治愈还是并发症的循环?)
Indian J Microbiol. 2024 Sep;64(3):810-820. doi: 10.1007/s12088-024-01267-w. Epub 2024 Apr 3.
10
Postbiotic Impact on Host Metabolism and Immunity Provides Therapeutic Potential in Metabolic Disease.后生元对宿主代谢和免疫的影响为代谢性疾病提供了治疗潜力。
Endocr Rev. 2025 Jan 10;46(1):60-79. doi: 10.1210/endrev/bnae025.

本文引用的文献

1
Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice.乙醛脱氢酶 2 缺乏症可改善酒精性脂肪肝,但会加重小鼠的肝炎症和肝纤维化。
Hepatology. 2014 Jul;60(1):146-57. doi: 10.1002/hep.27036. Epub 2014 May 28.
2
Role of the intestinal microbiome in liver disease.肠道微生物组在肝病中的作用。
J Autoimmun. 2013 Oct;46:66-73. doi: 10.1016/j.jaut.2013.07.001. Epub 2013 Sep 24.
3
Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance.肠道细菌过度生长:发病机制与临床意义。
Ther Adv Chronic Dis. 2013 Sep;4(5):223-31. doi: 10.1177/2040622313496126.
4
Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment.酒精诱导的肠道微生物组病理改变的宏基因组学分析及鼠李糖乳杆菌 GG 治疗的效果。
PLoS One. 2013;8(1):e53028. doi: 10.1371/journal.pone.0053028. Epub 2013 Jan 9.
5
Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.非酒精性脂肪性肝炎(NASH)患者肠道微生物组的特征:内源性酒精与 NASH 之间的联系。
Hepatology. 2013 Feb;57(2):601-9. doi: 10.1002/hep.26093. Epub 2013 Jan 8.
6
Role of gut microbiota in liver diseases.肠道微生物群在肝脏疾病中的作用。
Hepatol Res. 2013 Feb;43(2):139-46. doi: 10.1111/j.1872-034X.2012.01088.x. Epub 2012 Sep 13.
7
Host-gut microbiota metabolic interactions.宿主-肠道微生物群代谢相互作用。
Science. 2012 Jun 8;336(6086):1262-7. doi: 10.1126/science.1223813. Epub 2012 Jun 6.
8
Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.肠-肝轴:肠道微生物群对非酒精性脂肪性肝病的影响。
Nutr Metab Cardiovasc Dis. 2012 Jun;22(6):471-6. doi: 10.1016/j.numecd.2012.02.007. Epub 2012 Apr 28.
9
Probiotics in the gastrointestinal diseases of the elderly.老年人胃肠道疾病中的益生菌。
J Nutr Health Aging. 2012 Apr;16(4):402-10. doi: 10.1007/s12603-011-0357-1.
10
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease.肝病小鼠模型中的细菌易位和肠道微生物组的变化。
J Hepatol. 2012 Jun;56(6):1283-92. doi: 10.1016/j.jhep.2012.01.019. Epub 2012 Feb 9.